Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
- 1 November 2017
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 113, 140-151
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic settingBMC Health Services Research, 2013
- Health-related quality of life questionnaires in lung cancer trials: a systematic literature reviewHealth Economics Review, 2013
- Quality of life predicts survival in patients with non-small cell lung cancerBMC Public Health, 2012
- Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer SurvivalJNCI: Journal of the National Cancer Institute, 2011
- Reliability of adverse symptom event reporting by cliniciansQuality of Life Research, 2011
- Health-Related Quality of Life in Non–Small-Cell Lung Cancer: An Update of a Systematic Review on Methodologic Issues in Randomized Controlled TrialsJournal of Clinical Oncology, 2011
- Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001Value in Health, 2003
- SF-36 Health Survey UpdateSpine, 2000
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992